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Members of the SoxB transcription factor family play critical roles in the regulation of neurogenesis. The
SoxB1 proteins are required for the induction and maintenance of a proliferating neural progenitor
population in numerous vertebrates, however the role of the SoxB2 protein, Sox21, is less clear due to
conﬂicting results. To clarify the role of Sox21 in neurogenesis, we examined its function in the Xenopus
neural plate. Here we report that misexpression of Sox21 expands the neural progenitor domain, and
represses neuron formation by binding to Neurogenin (Ngn2) and blocking its function. Conversely, we
found that Sox21 is also required for neuron formation, as cells lacking Sox21 undergo cell death and
thus are unable to differentiate. Together our data indicate that Sox21 plays more than one role in
neurogenesis, where a threshold level is required for cell viability and normal differentiation of neurons,
but a higher concentration of Sox21 inhibits neuron formation and instead promotes progenitor
maintenance.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Neurogenesis, the progression of neural stem cells to committed
neurons, is a tightly regulated process that is fundamental for the
development of the central nervous system (CNS) and neuron
regeneration. Although many of the proteins involved in this process
have been identiﬁed (Moody et al., 2013; Rogers et al., 2009b; Suh
et al., 2009, 2007), the coordination of the steps required to maintain a
balance of proliferating neural stem cells and differentiating neurons
is not well understood. To characterize the regulatory factors that
drive neurogenesis, we looked to the SoxB family of transcription
factors, which play critical roles in neural stem cell induction,
maintenance, and neuronal differentiation (Bergsland et al., 2006;
Bylund et al., 2003; Kiefer, 2007; Rogers et al., 2009b, 2008; Sandberg
et al., 2005).
The 20 vertebrate Sox proteins contain a conserved high mobility
group (HMG) DNA-binding domain, which interacts with the minor
groove of the DNA helix to cause it to bend (Kamachi and Kondoh,
2013; Kiefer, 2007). The SoxB proteins also share a conserved eight
amino acid Group B homology domain located adjacent to the HMG
domain (Kamachi et al., 1995; Uchikawa et al., 1999). The SoxB group
is further divided into SoxB1 and SoxB2 subgroups based on both
sequence homology and function (Uchikawa et al., 1999).
The SoxB1 proteins (Sox1, 2 and 3), which act as transcriptional
activators (Bylund et al., 2003; Kamachi et al., 1995; Rogers et al.,
2009a), are required for induction of the CNS and/or maintenance of a
proliferating neural progenitor population (Buescher et al., 2002;
Bylund et al., 2003; Graham et al., 2003; Rogers et al., 2009a;
Uchikawa et al., 1999). Overexpression of SoxB1 proteins represses
differentiation thereby allowing for the maintenance of a proliferative
progenitor population (Bylund et al., 2003; Graham et al., 2003;
Holmberg et al., 2008; Mizuseki et al., 1998; Rex et al., 1997; Rogers
et al., 2009a), and the loss of SoxB1 protein expression promotes
differentiation into neurons (Bylund et al., 2003). Whereas the SoxB1
proteins function primarily as activators, the closely related SoxB2
proteins (Sox14 and Sox21) function as repressors (Argenton et al.,
2004; Sandberg et al., 2005; Uchikawa et al., 1999) and have been
proposed to inhibit SoxB1 target genes to facilitate progression from
progenitor cell to neuron (Sandberg et al., 2005; Uchikawa et al.,
1999).
Although there has been intense study of the function of SoxB1
proteins, much less is known about how the SoxB2 proteins function
during neurogenesis. Work in chick, mouse, and frog has demon-
strated that the SoxB2 transcription factors are expressed in distinct
regions of the CNS during different stages in neural development,
unlike the SoxB1 proteins which are pan-neural. Whereas sox14 is
expressed later in development in distinct subsets of neurons
(Cunningham et al., 2008; Hargrave et al., 2000; Uchikawa et al.,
1999), sox21 is expressed in the neural plate during neurogenesis
(Cunningham et al., 2008), and is later limited to select regions of
the developing brain including the forebrain, midbrain–hindbrain
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boundary (MHB), the olfactory placodes (Cunningham et al., 2008;
Ohba et al., 2004; Rimini et al., 1999; Uchikawa et al., 1999), and the
spinal cord (Sandberg et al., 2005; Uchikawa et al., 1999). Like the
soxB1 genes, sox21 is expressed in neural progenitors and cells that
express the proneural gene neurogenin (ngn2), but is not expressed
in post-mitotic neurons (Ohba et al., 2004; Sandberg
et al., 2005) as is its counterpart sox14 (Hargrave et al., 2000).
It is postulated that Sox21 regulates soxB1 expression in the
developing CNS, however functional data are in conﬂict. Gain-of-
function studies showed that Sox21 counteracts SoxB1 activation of a
reporter construct in chick lens cells (Uchikawa et al., 1999), promotes
neuronal differentiation in the chick spinal cord (Sandberg et al.,
2005) and the dentate gyrus of the adult hippocampus (Matsuda et al.,
2012), and promotes differentiation of mouse embryonic stem cells
(ESCs) into neural stems cells (Mallanna et al., 2010). Yet, Sox21 has
also been implicated in the maintenance of progenitor proliferation
rather than in promotion of neuronal differentiation. For example,
Sox21 decreases neurite outgrowth induced by nerve growth factor
(NGF) in mouse PC12 cells (Ohba et al., 2004), indicating that it
inhibits maturation. Likewise, Sox21 levels are elevated in small cell
lung cancers suggesting a role in stimulating uncontrolled pro-
liferation (Titulaer et al., 2009). Furthermore, Sox21 is a direct target
of pluripotency factors such as Nanog, Oct4 and Sox2 in mouse ESCs
(Chakravarthy et al., 2011; Mallanna et al., 2010) and is essential for
maintaining progenitors, and induced pluripotency and reprogram-
ming by Sox2 (Kuzmichev et al., 2012). These studies suggest that
Sox21 functions similarly to SoxB1 proteins to maintain progenitors
and prohibit neuronal outgrowth, and that down-regulation of Sox21
may be required for differentiation to occur. Together these conﬂicting
results suggest that Sox21 does not have a single global function, but
instead has distinct, contextual functions in regulating neurogenesis.
In this study, we performed gain- and loss-of-function analyses of
Sox21 in Xenopus laevis embryos and explants to determine its
mechanism of action during primary neurogenesis. Our gain-of-
function assays show that Sox21 expanded the SoxB1 neural progeni-
tor domain and inhibited neuronal differentiation by binding to and
counteracting the activity of Ngn2. Conversely, our loss-of-function
studies demonstrate that the loss of Sox21 also reduced neuron
formation and induced cell death. Together our data indicate that
Sox21 plays more than one role in neurogenesis. A threshold level is
required for differentiation of neurons, whereas a higher concentra-
tion of Sox21 inhibits neurogenesis and instead promotes expansion
of SoxB1 expression and progenitor maintenance. Therefore our data
suggest that, like other Sox proteins, Sox21 functions in a dose/context
dependent manner. With this report we have clariﬁed the relationship
between Sox21 and SoxB1 proteins, suggesting that they have
cooperative functions in progenitor maintenance and inhibition of
differentiation. More importantly, we demonstrate that Sox21
enhances progenitor gene expression during early neurogenesis
in vivo by offsetting Ngn2 function and regulates the decision to
remain as a progenitor cell or become a neuron based on its level of
expression.
Results
Sox21 expands neural progenitors and inhibits neuronal
differentiation
To elucidate the function of Sox21 during neurogenesis, we
injected sox21 mRNA into one blastomere of a two-cell Xenopus
embryo, collected neurula embryos, and analyzed the expression of
sox3, ngn2, neuroD and n-tubulin, which are progenitor (Bylund et al.,
2003), proneural (Lee et al., 1995; Ma et al., 1996) and neuronal
(Chitnis et al., 1995) genes expressed in cells undergoing neurogenesis,
respectively. Overexpression of sox21 expanded the neural plate, as
evidenced by the expanded expression domains of sox3 and ngn2
(Fig. 1B). However, the expression of proneural gene neuroD, a direct
target of Ngn2 (Ma et al., 1996; Seo et al., 2007), and that of primary
neuron marker n-tubulin were both severely reduced (Fig. 1B). This
suggests that Sox21 functions to expand neural progenitors and
repress neuronal differentiation.
To determine if X. laevis Sox21 acts as a repressor or activator, we
replaced the C-terminal domain of Sox21 with the Engrailed (EnR)
repression domain or the VP16 activation domain (Fig. 1A). We
injected mRNA into one blastomere of two-cell embryos and
analyzed the expression of sox3, ngn2, and n-tubulin. Overexpression
of sox21EnR phenocopied Sox21 and expanded the neural plate as
marked by sox3, and reduced neuron formation as indicated by a
repression of n-tubulin expression. Sox21-VP16 grossly expanded both
sox3 and n-tubulin (Fig. 1C). This indicates that Sox21 functions as a
repressor in its role of expanding neural progenitors and inhibiting
neuronal differentiation.
The onset of sox21 expression occurs during early gastrulation,
however its expression peaks at mid-neurula stage (Cunningham
et al., 2008). To examine the effect of overexpression later in
development, we tested the function of the hormone-inducible
form of Sox21, in which the Glucocorticoid receptor (GR) binding
domain is fused to the N-terminus of full length Sox21 (Fig. 1A).
The induction of GR-Sox21 by incubation of gastrulae in dexa-
methasone (DEX) phenocopied sox21 mRNA injections: expansion
of sox3 and repression of n-tubulin in neurula and tailbud embryos
(Fig. 1D). This indicates that the effects of Sox21 overexpression do
not depend on its time of expression.
These results were unexpected, considering that in the chick
embryonic spinal cord, increasing levels of Sox21 were proposed
to promote neuronal differentiation (Sandberg et al., 2005). To
determine if this function was speciﬁc to X. laevis Sox21, we
injected chick sox21 mRNA (cSox21) into one blastomere of two-
cell Xenopus embryos. cSox21 also expanded sox3 expression and
repressed n-tubulin (Fig. 1E). Additionally, we analyzed the expres-
sion of mouse Sox21 mRNA (mSox21) in the cortex during
neurogenesis (E10.5–P10) using RT-PCR, and found that its expres-
sion mirrors that of mSox3 and mSox2, and is reduced prior to the
onset of neuronal differentiation marked by the expression of
proneural gene Ngn2 and neuronal gene Tubb3 (unpublished data).
These results support the hypothesis that the early role of Sox21 is
to promote neural progenitor formation or maintenance and
inhibit neuronal differentiation, and the phenotypic differences
are not due to species differences in protein sequence or function.
Sox21 enhances neural progenitor induction by Noggin
To determine if Sox21 alone is sufﬁcient to induce the forma-
tion of neural progenitors or if it facilitates the induction of
progenitors by Noggin, we employed an ectodermal explant assay
(Slack and Forman, 1980), which allows for the assessment of
molecular function in the absence of other fate-inducing signals
provided by the embryo. We injected one-cell embryos with sox21,
low or high levels of noggin, or the combination of noggin and
sox21 mRNAs, and used quantitative RT-PCR to analyze the
expression of neural progenitor genes in neurula staged explants.
Noggin is sufﬁcient to induce the expression of progenitor genes
sox2 and sox3 (Rogers et al. 2008; Fig. 2A, dark blue bars) and
neural competence genes foxd5a (Yan et al., 2009) and zicr1 (Kuo
et al., 1998) with little neuron formation (Lamb et al., 1993; Rogers
et al., 2011; Fig. S1, dark blue bars). Neither a low level of noggin
(light blue bars), nor sox21 alone (yellow bars) induced expression
of sox2, sox3 (Fig. 2A), foxd5a or zicr1 (Fig. S1). However, the com-
bination of low noggin with sox21 (green bars) induced the
expression of sox2, sox3, foxd5a, and zicr1 to levels comparable
to that of high noggin alone (dark blue bars) (Fig. 2A, Fig. S1). This
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indicates that Sox21 and Noggin synergistically induce progenitor
gene expression in naïve ectoderm. We veriﬁed this synergy
in vivo by in situ hybridization (ISH) of sox3 in embryos injected
with low noggin and/or sox21 mRNA in the ventral blastomeres of
four-cell embryos. Low levels of noggin induced a secondary axis
marked by sox3 in 20% of injected embryos (n¼4/19), however
sox21 and noggin together induced a secondary axis in 60% of
injected embryos (n¼17/29) (Fig. 2B). This capacity to convert
ectoderm to a neural fate was strictly due to collaboration with
noggin, as sox21 alone neither affected epidermis formation
marked by epi-keratin expression (Fig. 2C), nor induced a second-
ary axis when overexpressed in ventral cells (Fig. 2B, n¼23/29
unchanged). To determine if a higher amount of sox21 expression
has the capacity to convert ventral ectoderm to neural tissue, we
injected 400 pg of GR-sox21 mRNA and induced expression during
late gastrula stage. While there was a slight decrease in epi-keratin
expression, sox3 was not expressed in these ventral cells (Fig. 2D).
This suggests that at a high level Sox21 interferes with epider-
mis formation, but does not induce a neural fate in non-neural
ectoderm.
These data demonstrate that Sox21 facilitates neural progenitor
induction by Noggin. In fact, Noggin induces sox21 expression in
ectodermal explants (Fig. 3A). To determine if Noggin requires Sox21
to induce neural progenitor gene expression, we inhibited Sox21
protein translation in ectodermal explants with antisense morpholi-
nos (MOs). We injected noggin mRNA with increasing amounts of
Sox21MO2, and used quantitative RT-PCR to analyze the expression of
progenitor genes in mid-neurula staged explants. We found that with
increasing amounts of MO2, sox2 and sox3 expression signiﬁcantly
decreased and epi-keratin expression signiﬁcantly increased in a dose-
dependent manner (Fig. 3B). Thus, Noggin requires Sox21 to maintain
or induce the expression of neural progenitor markers in neurulae. We
next asked if Sox21 was required for onset of Sox2 expression, which
is induced in mid-gastrula stage explants (Rogers et al., 2008). When
Sox21 levels were reduced, sox2 was not expressed in response to
Noggin by the mid-gastrula stage (Fig. 3C), suggesting that Noggin
requires Sox21 to induce a neural fate.
Sox21 interferes with Ngn2 function
Our data show that Sox21 promotes progenitor maintenance and
inhibits neuronal differentiation, as the expression of neuroD and
n-tubulin (Fig. 1B) is repressed by Sox21 misexpression. However,
overexpression of Sox21 does not decrease the level of ngn2 (Fig. 1B).
One possibility is that Sox21 prevents neuronal differentiation by
blocking Ngn2 function, but does not affect ngn2 transcription. To
test this, we injected sox21, ngn2 or the combination of mRNAs into
embryos and analyzed the expression of Ngn2 target genes in
neurula stage explants using quantitative RT-PCR (Fig. 4A). While
Ngn2 is sufﬁcient to induce the expression of neuroD, myT1 and
n-tubulin in explants (Bellefroid et al., 1996; Ma et al., 1996; Seo
et al., 2007; Fig. 4A, blue bars), the addition of Sox21 signiﬁcantly
reduced the expression of these genes (Fig. 4A, green bars),
Fig. 1. Sox21 functions as a repressor to expand neural progenitors and inhibit neuronal differentiation. (A) Diagram of Sox21 proteins used in overexpression studies.
(B) In situ hybridization (ISH) of neurula stage embryos injected with sox21 mRNA on right side and analyzed for sox3, ngn2, neuroD or n-tubulin expression. (C) ISH of
neurula stage embryos injected with sox21-EnR or sox21-VP16 mRNA on right side and analyzed for sox3, ngn2 or n-tubulin expression. (D) ISH of embryos injected with
hormone-inducible GR-sox21 mRNA and analyzed for sox3 or n-tubulin expression. Right: Transverse section of GR-sox21 injected tailbud embryo following ISH for sox3.
(E) ISH of embryos injected with chick sox21 mRNA and analyzed for sox3 or n-tubulin expression.
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indicating that Sox21 inhibits neurogenesis by counteracting Ngn2
function.
Ngn2 binds directly to enhancer regions to activate transcrip-
tion of target genes such as neuroD and myT1 (Seo et al., 2007). To
determine if Sox21 binds to Ngn2 to interfere with Ngn2 function,
we performed a co-immunoprecipitation (co-IP) assay using
in vitro translated Sox21-FLAG and Ngn2-myc proteins. We found
that Ngn2-myc co-precipitates with Sox21-FLAG, and this interac-
tion was speciﬁc to Ngn2 as mCherry-myc did not co-precipitate
with Sox21-FLAG (Fig. 4B, top). We also examined the interaction
of Sox21 with Sox2, which have been shown to be expressed in the
same cells (Kuzmichev et al., 2012; Ohba et al., 2004; Sandberg
et al., 2005) and interact in mouse embryonic stem cells (Mallanna
et al., 2010), and conﬁrmed that Xenopus Sox2 and Sox21 proteins
also interact as reported (Fig. 4B, bottom). Hence, Sox21 interacts
with both Ngn2 and Sox2, and these interactions may alter its
function during neurogenesis.
Sox21 is required for neuron formation
Our data indicate that Sox21 plays an important role in regulating
the progression of neurogenesis; wherein it inhibits neuron formation
in favor of progenitor cell expansion. To determine if Sox21 is required
in the embryo for progenitor formation, we injected Sox21 MOs into
one dorsal blastomere of four-cell embryos and analyzed the resulting
expression of progenitor, proneural and neuronal genes by ISH.
Knocking down Sox21 did not affect expression of progenitor marker
sox2 (Fig. 5A), or the proneural gene ngn2 (Fig. 5A). To conﬁrm this
result, we injected Sox21MO2 into one-cell embryos and used
quantitative RT-PCR to quantify the expression of sox2, ngn2, and
epi-keratin. At stage 11 the expression of sox2 and ngn2 were reduced
by 30% compared to untreated controls (Fig. 5B). Additionally, the
expression of epi-keratin was slightly increased (Fig. 5B), suggesting
that with a decrease in Sox21, more ectodermal cells undergo an
epidermal fate. We also found that the expression levels of neuroD and
the neuron marker n-tubulin were drastically reduced (Fig. 5A, red
asterisks), suggesting that Sox21 is also required for subsequent
neuron formation. To test this, we injected ngn2 mRNA and
Sox21MO1 into embryos and analyzed changes in Ngn2 target gene
expression in neurula explants by quantitative RT-PCR (Fig. 5C). The
reduction of Sox21 severely decreased the expression of Ngn2 targets
neuroD and myT1 and of n-tubulin, indicating that even though high
levels of Sox21 inhibits Ngn2, some Sox21 is required for activation of
Ngn2 targets and ultimately for neuron formation (Fig. 5C). We
conﬁrmed this in embryos by injecting ngn2 and Sox21MO1 into
one blastomere of four-cell embryos and assaying for ectopic neurons.
The lack of Sox21 reduced induction of ectopic n-tubulin by Ngn2
(Fig. 5D). Given that neuronal and progenitor gene expression was
absent or reduced in Sox21-deﬁcient cells, we asked if this was in part
due increased cell death. We assayed for cell death using TUNEL in
Fig. 2. Sox21 facilitates neural progenitor induction by Noggin. (A) Quantitative RT-PCR analysis of sox2 and sox3 expression in neurula stage ectodermal explants isolated
from embryos injected with low (þ) or high (þþþ) levels of noggin mRNA with or without sox21 mRNA at the 1-cell stage. n indicates signiﬁcance by Student's t-test
(po0.05) compared to both sox21 and low noggin alone. (B) Graph of secondary axis phenotype for embryos injected with low (þ) or high (þþ) nogginA3 mRNA with or
without sox21 into one ventral blastomere, and analyzed by ISH for sox3. (C) ISH of a single neurula stage embryo injected with sox21 mRNA and analyzed for epi-keratin
expression. (D) ISH of embryos injected into one ventral blastomere with hormone-inducible GR-sox21 mRNA, and analyzed for sox3 or epi-keratin expression. n indicates
reduced expression.
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embryos injected with Sox21MO1 or MO2. We found that embryos
injected with Sox21MO exhibited increased TUNEL staining on the
injected side compared to the uninjected side (Fig. 5E).
Our data indicate that both reduction and overexpression of
Sox21 block neuron formation. One possibility is that the level of
Sox21 must be ﬁnely tuned in a developing cell in order for neuron
formation, and that the level of Sox21 expression determines its
function during neurogenesis. To examine this further, we injected
increasing amounts of GR-sox21 mRNA into one blastomere of four-
cell embryos, induced expression of Sox21 at late gastrula, and
analyzed changes in the expression of sox3 and n-tubulin by ISH in
neurula embryos (Fig. 6). We found that 25 pg of GR-sox21 expanded
sox3 in approximately 18% of injected embryos (n¼3/17), 50–100 pg
expanded sox3 in 43% of injected embryos (n¼13/30, 9/21 respec-
tively), and 400 pg of GR-sox21 expanded sox3 in 87% of injected
embryos (n¼14/16). In contrast, 25 pg of GR-sox21 was sufﬁcient to
reduce n-tubulin expression in 46% of injected embryos (n¼13/28),
and 50 pg reduced n-tubulin in 69% (n¼22/32). Thus, a lower
concentration of GR-sox21 (50 pg) is sufﬁcient to inhibit differentia-
tion, whereas eight-fold higher concentration is required for pro-
genitor expansion. Considered with the MO knockdown data, this
indicates that a low level of Sox21 is needed for n-tubulin expression
and cell survival, whereas a high level of Sox21 expands sox3 and
inhibits n-tubulin expression. This suggests that the level of Sox21
expression dictates its targets, and therefore its functions during
neurogenesis. Ultimately, the level of Sox21 expression directs if and
how a neural progenitor cell will progress through neuronal
differentiation.
Discussion
SoxB transcription factors play important roles in the regulation of
neurogenesis. Prior studies have indicated that Sox21 drives neuronal
Fig. 3. Sox21 is required for the induction and maintenance of sox2 expression. (A) RT-PCR analysis of sox21 expression in neurula stage ectodermal explants isolated from
untreated embryos and those injected with noggin at the 1-cell stage. Reference gene ef1a was used as a loading control. (B) Quantitative RT-PCR analysis of sox2, sox3, and
epi-keratin expression in mid-neurula stage ectodermal explants isolated from embryos injected with noggin, Sox21MO2, mismatch MO (mmMO) or in combination
(as indicated) at the 1-cell stage. n indicates signiﬁcance by Student's t-test (po0.05) compared to noggin alone. (C) Quantitative RT-PCR analysis of sox2 expression in early
gastrula (stage 11) ectodermal explants isolated from embryos injected as in B.
N. Whittington et al. / Developmental Biology 397 (2015) 237–247 241
differentiation (Sandberg et al., 2005; Uchikawa et al., 1999), while
others indicate that it is involved in the maintenance of progenitor
populations (Ohba et al., 2004; Kuzmichev et al., 2012; Titulaer et al.,
2009). Due to these observed differences, we sought to clarify its role
and to deﬁne its mechanism for action during neurogenesis in the
neural plate.
In this study, we investigated the role of Sox21 during neuro-
genesis using gain- and loss-of-function. At a high level of
expression, Sox21 expanded progenitor cells at the expense of
differentiation. This is in line with other reports suggesting that
Sox21 functions in the maintenance of a proliferating progenitor
cell population (Kuzmichev et al., 2012; Ohba et al., 2004). We also
discovered that Sox21 inhibited neurogenesis by speciﬁcally block-
ing Ngn2 from activating its downstream targets neuroD, myT1 and
subsequently n-tubulin (Fig. 4A). We determined that Sox21
interacts with Ngn2 (Fig. 4B), indicating that together they bind
and repress Ngn2 target genes, or that Sox21 sequesters Ngn2 and
prevents it from activating target genes, thus allowing for
enhanced progenitor gene expression. It is unclear which region
of the Sox21 protein is required for its squelching activity of Ngn2.
While some Sox partner interactions involve the HMG domain,
others interact on regions outside of the DNA binding domain
(Bernard & Harley, 2010). Future studies will reveal where Sox2
and Ngn2 interact with Sox21.
Previous studies have shown that SoxB1 protein Sox2 activates
Sox21 expression (Chakravarthy et al., 2011; Kuzmichev et al.,
2012), and we show here that sox21 overexpression enhances sox2
expression (Fig. 1F). Likewise, we have found that the reduction of
Sox21 reduces sox2 expression (Fig. 3B and C), and a decrease in
Sox2 reduces sox21 expression (unpublished data). Thus, a Sox2–
Sox21 partnership could present a feedback loop by which Sox2
and Sox21 maintain each other's expression to generate and/or
maintain a progenitor pool and inhibit differentiation. As Sox21 is
a known target of reprogramming factors like Sox2 (Kuzmichev
et al., 2012), our work suggests that it may be useful for future
work investigating induced pluripotency.
Sox21 is not sufﬁcient to directly induce SoxB1 expression in
ectoderm tissue. Instead, Sox21 works synergistically with Noggin,
a BMP antagonist, to induce ectoderm cells to undergo a neural
fate (Fig. 2, green bars; Fig. 2B and D). Therefore it is likely that
Sox21 facilitates Noggin activity, or is used as an additional aide to
maintain cells in a progenitor state, rather than as a neural
induction agent. Since Noggin both activates Sox21 as well as
promotes SoxB1 expression, one possibility is that Noggin employs
Sox21 to induce, maintain, or enhance sox2 and sox3 in ectodermal
explants.
This role in progenitor maintenance is also supported by the
expression pattern of sox21; it is highly expressed in the foreb-
rain, mid–hindbrain boundary (MHB) and olfactory placodes
(Cunningham et al., 2008), which are regions characterized by
delayed neurogenesis (Baek et al., 2006; King-Robson, 2011;
Stigloher et al., 2008). This suggests that Sox21 may be utilized
Fig. 4. Sox21 inhibits the expression of neuronal differentiation genes and binds to Ngn2 to counteract its function. (A) Quantitative RT-PCR analysis of neuroD, myT1,
n-tubulin and sox2 expression in neurula stage ectodermal explants isolated from embryos injected with ngn2, sox21, or ngn2þsox21. n indicates signiﬁcance by Student's
t-test (po0.05) compared to ngn2 alone. (B) Co-Immunoprecipitation (co-IP) of in vitro translated (IVT) Sox21-FLAG protein with Ngn2-myc or mCherry-myc proteins (top),
or Sox2-HA (bottom) protein.
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during brain development to maintain a pool of progenitors as
other cells differentiate, perhaps to form a properly sized brain.
Sox21 is also expressed in the ventricular zone of the embryonic
mouse cortex and crypts of the gut, where it overlaps with the
expression of progenitor marker Nestin (Ohba et al., 2004) and
SoxB1 proteins (Kuzmichev et al., 2012; Sandberg et al., 2005), as
well as in neurospheres isolated from the mouse cortex (unpub-
lished data). We have also seen that during corticogenesis, its
expression mirrors that of progenitor markers sox2 and sox3, and
its expression decreases as differentiation factors such as ngn2 and
tubb3 increase to signal neuron development (unpublished data).
These ﬁndings provide evidence that the behavior of Sox21 may be
contextual and regulated by other environmental factors that
differ between regions of the nervous system.
While our gain-of-function data show that Sox21 plays a role in
progenitor maintenance and differentiation inhibition, our loss-of-
function data suggest that Sox21 is required for cell viability and early
neuron development. Therefore at some minimal threshold level,
Sox21 must be expressed for neuron formation to occur in a normally
developing embryo. We note that in ectodermal explants, Sox21 is
required for the expression of SoxB1 progenitor genes. This was not
immediately evident in whole embryos, however quantitative RT-PCR
revealed a decrease in the expression of soxB1 genes (Fig. 5B). In the
embryo, there are multiple pathways that converge to induce neural
Fig. 5. The loss of Sox21 reduces neuron formation and increases apoptosis in embryos. (A) ISH of neurula stage embryos injected on right side with Sox21 morpholino MO1
(top) or ﬂuorescent morpholino MO2 (bottom) and analzed for expression of neurogenesis genes. Asterisks indicate a loss of expression. (B) Quantitative RT-PCR analysis of
sox2, ngn2 and epi-keratin expression in gastrula stage embryos injected with Sox21MO2. n indicates signiﬁcance by Student's t-test (po0.05) compared to uninjected
embryos. (C) Quantitative RT-PCR analysis of neuroD, myT1, and n-tubulin expression in neurula stage ectodermal explants isolated from embryos injected with ngn2 mRNA,
Sox21MO1, or the combination as indicated. n indicates signiﬁcance by Student's t-test (po0.05) compared to ngn2 alone. (D) ISH of neurula stage embryos injected on right
side with ngn2 mRNA and MO1 (as indicated) and analyzed for n-tubulin expression. (E) TUNEL staining of embryos injected with MO1 or MO2. n indicates signiﬁcance by
Student t-test (po0.05) compared to the control group.
N. Whittington et al. / Developmental Biology 397 (2015) 237–247 243
genes (Marchal et al., 2009; Rogers et al., 2011). In our ectodermal
explants, Noggin is the only neuralizing factor present. Thus while
Noggin may require Sox21 for its induction of SoxB1 proteins, other
factors that are present in the embryo may compensate and allow for
some SoxB1 expression in a Sox21-reduced environment. However
despite this compensation, there are fewer neural progenitors as well
as an increase in cell death in the absence of Sox21. One interpretation
is that progenitors cannot exit the cell cycle, or that they exit the cell
cycle but cannot differentiate, and as a result apoptose. In support of
this, a study showed that the protein Cdh1 is required for both cell
cycle exit and differentiation, and that its loss delayed cell cycle exit
and led to increased apoptosis (Delgado-Esteban et al., 2013). There is
no evident accumulation of progenitor cells due to the reduction of
Sox21, therefore we conclude that it is not likely that the cells cannot
exit the cell cycle, but instead that the progenitor cells that are present
are unable to differentiate and therefore die as a result. This suggests
that Sox21 plays some early role in cell survival. We have also
observed that increasing the amount of sox21 mRNA injected by
1.5X is lethal during embryonic gastrulation (unpublished data).
Therefore it is possible that Sox21 acts on a target involved in cell
cycle regulation, and precise regulation of its expression is required for
cell survival and differentiation.
Thus, we ﬁnd that Sox21 has multiple roles based on its level
and spatiotemporal expression. At a high level, Sox21 inhibits
neuron formation by interacting with Ngn2 to promote progenitor
maintenance (Fig. 7); however some Sox21 expression is required
for cell survival and ultimately neuron formation. As such, our
model proposes that the level of Sox21 expression within a neural
cell regulates how it will progress during neurogenesis. When
Sox21 is severely reduced, neural progenitor cells will undergo cell
death as cells exit the cell cycle but are unable to differentiate, or
as cells are stuck in the cell cycle. With a minimal level of Sox21
expression, these cells differentiate to become neurons. Yet when
slightly increased, Sox21 inhibits neurogenesis, and as more Sox21
is expressed, it also expands the neural plate by enhancing SoxB1
expression, potentially through its interaction with Sox2.
Other Sox proteins, including Sox2, have been shown to function
in a dose-dependent manner (Hutton and Pevny, 2011; Taranova
et al., 2006). Because all SOX proteins recognize the same DNA-
binding sequence (A/T) (A/T) CAA(A/T)G (Harley et al., 1994), it is
understood that Sox proteins cooperate with other region-speciﬁc
transcription factor partners to regulate expression of their speciﬁc
down-stream target genes (Kamachi et al., 2000). Therefore in
different cells or at different times in development, the Sox proteins
interact with different partners and as a result have different
functions. However, despite their importance very few partner
interactions have been conﬁrmed in vivo. We have shown that
interaction with a partner Oct4 allows for the three SoxB1 proteins
to activate unique neural targets during neurogenesis (Archer et al.,
2011). Another Sox protein, Sox10, performs multiple functions
during glial development based on its interaction with different
transcription factors and epigenetic modiﬁers (Weider et al., 2013).
Sox21 function and its role in neurogenesis may also depend on the
interaction of different partner proteins based on its level of
expression. In addition to its roles in neurogenesis, Sox21 has also
been shown to be required for the development of other organs,
including sensory epithelium in developing cochlea (inner ear) of
mice (Hosoya et al., 2011) and the cuticle layer and the progenitor
cells of the hair shaft in both mouse and human (Kiso et al., 2009).
Again this suggests that its multiple roles in development may be
speciﬁed by cooperation with different partners in different envir-
onments at different times during development.
Materials and methods
Embryo culturing and manipulations
X. laevis embryos were obtained using standard methods (Sive
et al., 2000) and staged according to Nieuwkoop and Faber (1994).
Ectodermal explants were obtained by excising naïve ectoderm from
the animal pole of stage 8–9 embryos, and culturing them in 0.75X
Normal Amphibian Medium (NAM) (Slack and Forman, 1980) with
gentamycin. Explants were collected in sets of 20 per treatment when
uninjected sibling embryos reached stages 11, 13, 14, or 16.
Plasmid construction
Sox21HMG-VP16 was constructed by amplifying the N-terminus
and sox21 HMG box via PCR using the forward SP6 primer and
Fig. 6. Sox21 affects neural gene expression in a dose-dependent manner. Embryos were injected with the indicated amounts of GR-sox21 mRNA and analyzed by ISH for
changes in sox3 and n-tubulin expression. Graphs are data from a single representative experiment, which was performed three times and displayed the same trend. n¼total
number of injected embryos analyzed in one experiment. n Indicates signiﬁcance by Chi-square test (po0.05) compared to uninjected (0 pg) alone. indicates signiﬁcance
by Chi-square test (po0.05) compared to other doses (25–200 pg).
Fig. 7. Model for function of Sox21 during neurogenesis. Sox21 is induced by
Noggin and maintains cells in a progenitor state by binding to Ngn2 to inhibit
neuronal differentiation and expand the expression of the soxB1 genes when
expressed at a high level.
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reverse: 50-CGAGATCTCCCTGTAAACCCATAGGGC-30 primer, and ligat-
ing the digested PCR product into a p-Bluescript vector containing the
VP16 activator domain (Brickman et al., 2000). Sox21HMG-EnR was
constructed in a similar manner via PCR using the following prim-
ers: forward 50-CCGCTCGAGGGGACCCCGGGCAACGAG-30 and reverse
50-CCATCGATGTCCCCTGTAAACCCATAGGG-30. The digested PCR pro-
duct was ligated into a p-Bluescript vector containing amino acids 2–
298 of the Drosophila Engrailed (EnR) protein, then subcloned into the
pCS2þ expression vector. Chick sox21was obtained from J. Muhr, and
subcloned into the pCS2þ expression vector. Sox21-FLAG
was constructed by amplifying full length sox21 via PCR using the
following primers: forward 50-GCAGGATCCATGTCTAAACCGCTGGAT
CATG-30 and reverse 50-TGCCTCGAGTCACTTGTCATCGTCATCTTTA-
TAATCTAATGCTGCCGCATAGGCTG-30 (FLAG sequence underlined),
and ligating into pCS2þ expression vector. Sox2-HA was constru-
cted in a similar manner by PCR-amplifying sox2 using the following
primers: forward 50-GCAGAATTCATGTACAGCATGATGGAGACC-30 and
reverse 50-TGCCTCGAGTCAAGCGTAATCTGGAACATCGTATGGGTACATG
TGCGACAGAGGCAGC-30 (HA sequence underlined), and ligating into
pCS2þ expression vector.
mRNA and morpholino microinjections
Synthetic capped mRNA was made by in vitro transcription
using mMessage mMachine kits (Ambion). Amounts injected for
in situ hybridization (ISH) analyses in whole embryos were as
follows: 150 pg sox21, 200 pg sox21HMG-EnR, 250 pg sox21HMG-
VP16, 200 or 400 pg GR-sox21, 150 pg chick sox21, 25 pg or 50 pg
noggin A3 (Smith and Harland, 1992), 40 ng Sox21MO1 (Gene
Tools), and 40 ng Sox21MO2 (Gene Tools). For the dose depen-
dence assay, 25, 50, 100, 200, and 400 pg GR-sox21 mRNA were
injected. GR was induced with 10 mM dexamethasoneþ0.2% BSA
at stage 12 or 12.5. All embryos were injected at the two- or four-
cell stage and include 300 pg lacZ mRNA as a tracer, except for
Sox21MO2 which is tagged with lissamine as a ﬂuorescent tracer.
Embryos were cultured until stages 14–15 and analyzed by ISH.
For ectodermal explant assays, the following amounts were
injected: 100 pg sox21mRNA, 8 pg (low) or 28 pg (high) noggin
mRNA (Knecht et al., 1995), 290 pg ngn2 (Ma et al., 1996) mRNA,
10–40 ng Sox21MO2, 40 ng mismatch MO (Gene Tools), and 40 ng
Sox21MO1. Embryos were injected at the one-cell stage, and the
explants were analyzed by reverse transcription-polymerase chain
reaction (RT-PCR) or quantitative RT-PCR.
RT-PCR and qRT-PCR
RT-PCR was performed as described (Wilson and Hemmati-
Brivanlou 1995). Total RNA was extracted from 20 ectodermal
explants using either RNAqueous (Ambion) or PureLink (Invitrogen)
RNA extraction kits. cDNA was generated using random hexamers
and either MMLV reverse transcriptase (Fisher) or Tetro cDNA
synthesis kit (Bioline). Following cDNA synthesis, PCR was per-
formed using primers for ef1α (XMMR) to conﬁrm cDNA production,
and muscle actin (Hemmati-Brivanlou and Melton, 1994) to detect
mesoderm contamination. RT-minus samples were also assayed to
detect genomic DNA contamination.
qPCR was performed with Express SYBR Green Supermix
(Invitrogen) or SensiMix SYBR Green Mastermix (Bioline) in
MX3000P system (Strategene), or with SensiFAST SYBR Green Mas-
termix (Bioline) in CFX96 system (BioRad). Relative quantiﬁcation of
gene expression was determined using the ΔΔCt method (Livak and
Schmittgen, 2001). All samples were normalized to levels of reference
gene ef1a, which was used as the loading control, and analyzed
relative to untreated or control ectodermal explants. All samples were
analyzed in triplicate, and experiments were repeated at least twice.
Graphs in ﬁgures represent the mean fold change in expression of a
representative experiment, relative to control explants7standard
deviation. See Table S1 for primer sequences and qPCR conditions.
ISH and β-galactosidase assay
Whole mount in situ hybridization (ISH) was performed as
described (Harland, 1991; Hemmati-Brivanlou et al., 1990) except
RNAse treatments were omitted. For lineage tracing, β-gala-
ctosidase activity was visualized with X-gal (Research Organics).
Digoxygenin labeled mRNA probes were generated for sox2
(Mizuseki et al., 1998), sox3 (Penzel et al., 1997), ngn2 (Ma
et al., 1996), neuroD (Lee et al., 1995), epi-keratin (Jonas et al.,
1985) and n-tubulin (Richter et al., 1988).
Western blots and Co-IPs
In vitro translation (IVT) with 250 ng of mRNA was performed
using the TnT SP6 High-Yield Protein Expression System (Pro-
mega) to synthesize tagged proteins. 66% of this reaction was
subjected to co-IP while 33% was saved as input.
Co-immunoprecipitation (co-IP) was performed according to
(Singh et al., 2013). For each co-IP reaction, 10 ml reaction mix (66%)
was mixed with 650 ml cold TNSG lysis buffer (20 mM Tris pH 8,
137 mM NaCl, 10% glycerol, 1% NP-40) containing a protease inhibitor
cocktail tablet (Roche) and 2 mg/ml of anti-FLAG (Sigma), and incu-
bated for one hour on ice. Next, 25 ml Protein A/G agarose beads (Santa
Cruz) were added and the reactionwas incubated at 4 1C overnight on
an orbital mixer. Following this, beads were brieﬂy pelleted at 4 1C
and washed three times in ice-cold TNSG buffer. Buffer was decanted
and beads were resuspended in 50 ml 1X SDS sample buffer and boiled
at 100 1C for 5–10min. 12 ml of IP sample and 2.5 ml of input (also
boiled in 6X SDS sample buffer) were loaded onto 12.5% Tris–glycine
SDS polyacrylamide gels, resolved by electrophoresis, transferred to
nitrocellulose, and blocked in 5% non-fat dry milk in PBST (PBSþ0.1%
Tween-20) for one hour at room temperature. Following PBST rinse,
blots were incubated with anti-FLAG, anti-HA (Applied Biological
Materials), or anti-myc-HRP (Santa Cruz) primary antibodies for one
hour at room temperature, washed multiple times with PBST, then
incubated with anti-mouse lgG-HRP secondary antibody (Santa Cruz)
for one hour at room temperature. After PBST washes, blots were
incubated with Clarity chemiluminescent ECL substrate (Bio-Rad)
and imaged using ImaqeQuant LAS-4000 mini digital imager
(GE Healthcare).
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